Related Experiment Video
Updated: May 26, 2026

A Comprehensive Approach to Analyze the Cell Components of Cerebral Blood Clots
Published on: July 21, 2023
Management of the clotting system: a European perspective
Brigitte E Ickx1, David Faraoni
1Department of Anesthesiology, Hôpital Universitaire Erasme, Brussels, Belgium. brigitte.ickx@erasme.ulb.ac.be
Insights
Managing coagulation in cardiac surgery patients is complex due to aging populations and new antithrombotic drugs. This review covers perioperative treatments and monitoring for bleeding and coagulopathy.
Area of Science:
- Anesthesiology
- Cardiovascular Surgery
- Hematology
Background:
- Cardiovascular surgery patients are aging and have comorbidities, complicating coagulation management.
- Pre-existing treatments with anticoagulants and antiplatelet agents are common.
- Perioperative bleeding and coagulopathy pose significant risks.
Purpose of the Study:
- To review current knowledge and available treatments for coagulation management in cardiac surgery.
- To discuss new antithrombotic agents and their preoperative implications.
- To highlight advancements in bleeding and coagulopathy treatment and monitoring.
Main Methods:
- Literature review of perioperative coagulation management in cardiovascular surgery.
- Discussion of new antithrombotic drugs and their clinical use.
- Overview of hemostatic agents and monitoring devices available in Europe.
Main Results:
- New antithrombotic drugs increase the complexity of perioperative coagulation management.
- Various products for treating bleeding and coagulopathy are available in Europe.
- Novel monitoring devices, particularly for platelet function, are emerging.
Conclusions:
- Coagulation management in cardiac surgery is increasingly complex due to new pharmacotherapies.
- Improved and developed monitoring strategies are essential, especially for platelet function assessment.
- Effective perioperative management requires a comprehensive understanding of new agents and monitoring tools.
Purpose Of Review:
Coagulation management remains a challenge for anesthesiologists involved in cardiovascular surgery as the population undergoing surgery becomes older and presents with more comorbidities. These patients are frequently treated with one or more agents that directly affect coagulation. This review will discuss what is known and the treatments available to manage coagulation in the perioperative setting of cardiac surgery.
Recent Findings:
New antithrombotics will be discussed as well as their proposed substitution in the preoperative period. The review will also describe the different products available in Europe for the treatment of bleeding and coagulopathy. Finally, the use of new monitoring devices will be discussed.
Summary:
The introduction of new drugs with different mechanisms of action adds to the complexity of coagulation management during cardiovascular surgery. Monitoring needs to be developed and improved, especially for evaluating platelet function.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Venous Thrombosis IV: Nursing Management
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

